Cancer medicines

Rituximab

Rituximab

A CD20-targeting antibody used in selected B-cell lymphomas.

Sources checked · Introductory guide

On this page

How it works

It targets CD20 on B cells to help eliminate them.[3]

Where it is used

Used for CD20-positive non-Hodgkin lymphoma and certain chronic lymphocytic leukemias.[1]

Key safety points

Confirm hepatitis B screening before treatment. Report breathing difficulty, swelling or dizziness during infusion immediately.[2]

Questions for your care team

  • How will hepatitis B reactivation and infusion reactions be managed?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Rituximab (opens in a new tab)
  2. MedlinePlus · Rituximab (opens in a new tab)
  3. NCI · Rituximab mechanism (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Rituximab | Cancer Encyclopedia | My Chemo Diary